Traws Pharma, Inc. (TRAW): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$20.56M
As of 2023-12-31
-10.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $20.56M | -46.6% | 2024-04-01, Balance as of period end |
| 2022-12-31 | $38.52M | n/a | 2023-03-30, Balance as of period end |
| No annual figure between 2016-12-31 and 2022-12-31. | |||
| 2016-12-31 | $21.40M | +8.1% | 2017-03-29, Balance as of period end |
| 2015-12-31 | $19.80M | -54.6% | 2017-03-29, Balance as of period end |
| 2014-12-31 | $43.58M | -27.4% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $60.01M | -26.4% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $81.53M | n/m | 2015-03-30, Balance as of period end |
| 2011-12-31 | $2.71M | n/a | 2014-03-20, Balance as of period end |